Visit us at SBI 2026 Request a Demo

X

USA
- UK
- Canada

About
intelliMammo Platform
Solutions
Evidence
Discover
- Press
- Insight
Request a Demo

News & Press

Mount Sinai, Densitas and ACR ImPower Program Collaboration Increases the Quality of Mammography Positioning by 33%

Mount Sinai, Densitas and ACR ImPower Program Collaboration Increases the Quality of Mammography Positioning by 33%

October 14, 2025

Collaboration aligns teams on standardized positioning criteria, reduces inter-technologist variability, and lays the foundation for sustained, automated quality tracking with Densitas intelliMammo. [NYC, New York] – October 14, 2025 – Densitas has qualified for the American College of Radiology® (ACR®) Learning Network Vendor Partner designation. Through the ACR ImPower Mammography Positioning Improvement Collaborative, Densitas and the Mount Sinai Health System […]

Densitas: AI Identifies Persistent Mammography Positioning Challenges Impacting Screening Quality and Cancer Detection

Densitas: AI Identifies Persistent Mammography Positioning Challenges Impacting Screening Quality and Cancer Detection

July 9, 2025

Groundbreaking Mulitcenter MAMMO.IQ study demonstrates Densitas intelliMammo® plays a vital role in quantifying and identifying unmet positioning quality criteria. HALIFAX, NS, July 9, 2025 /PRNewswire/ – Results of a groundbreaking multicenter study involving 126,367 mammograms show that the use of artificial intelligence (AI) to evaluate mammography positioning on digital screening mammograms provides mammography positioning quality (MPQ) tracking at scale that reveals persistent unmet […]

AI Meets QI: Densitas and TungstenQI Launch Joint Continuous Quality Improvement Initiative

AI Meets QI: Densitas and TungstenQI Launch Joint Continuous Quality Improvement Initiative

April 21, 2025

HALIFAX, NS, Apr. 22, 2025 /PRNewswire/ – Densitas®, a global leader in artificial intelligence solutions for breast cancer screening, and TungstenQI Partners, a pioneering healthcare quality improvement consultancy, today announce a strategic partnership aimed at improving mammography positioning quality on a broad scale. This collaboration integrates Densitas’ intelliMammo® platform – an AI-powered solution designed for continuous quality improvement – with […]

Densitas Announces the Commercial Availability of intelliRisk, a High-Risk Breast Cancer Patient Management Platform

Densitas Announces the Commercial Availability of intelliRisk, a High-Risk Breast Cancer Patient Management Platform

March 20, 2025

Leader in Operational AI Solutions to Showcase its New Risk Offering at NCBC Annual Meeting in Las Vegas, March 21-23, 2025 HALIFAX, NS, March 20, 2025 – Densitas®, a global leader in artificial intelligence solutions for breast cancer screening, announces the commercial availability of intelliRisk™, its new high-risk breast cancer patient management platform following its successful debut at RSNA 2024. […]

Densitas / ACR Learning Network Strategic Collaboration to Improve Mammography Positioning

Densitas / ACR Learning Network Strategic Collaboration to Improve Mammography Positioning

November 25, 2024

The leading provider of Operational AI for Mammography collaborates with the ACR Learning Network in the ACR Mammography Positioning Improvement Collaborative to Advance Quality Standards in Mammography Positioning HALIFAX, NS, November 25, 2024 – Densitas®, a global leader in artificial intelligence (AI) solutions for breast cancer screening, is pleased to announce a strategic collaboration with the ACR Learning Network, an […]

Densitas Debuts intelliRisk, a High-Risk Breast Cancer Patient Management Platform

Densitas Debuts intelliRisk, a High-Risk Breast Cancer Patient Management Platform

November 13, 2024

Leader in Operational AI Solutions to Showcase Its New Offering at RSNA Annual Meeting in Chicago, December 1-4, 2024 HALIFAX, NS, November 13th, 2024 – Densitas®, a global leader in artificial intelligence solutions for breast cancer screening, announces the launch of intelliRisk™, its new high-risk breast cancer patient management platform. intelliRisk joins Densitas’ intelliMammo® and intelliMaven™ breast screening solutions as […]

Densitas Announces Strategic Collaboration with MTMI to Elevate Technologists’ Performance in Mammography

Densitas Announces Strategic Collaboration with MTMI to Elevate Technologists’ Performance in Mammography

October 2, 2024

The market leader in Operational AI for Mammography integrates MTMI’s educational content, including embedded positioning videos, into its intelliMammo® solution. HALIFAX, NS, October 2, 2024 – Densitas®, a global leader in artificial intelligence solutions for breast cancer screening, is excited to announce a strategic collaboration with the Medical Technology Management Institute (MTMI), a global leader in imaging continuing education. This […]

iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation

iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation

April 16, 2024

Provides a holistic breast health solution, including breast cancer screening focused on quality, safety and efficiency, breast cancer detection, breast density assessment, and risk evaluation Expands access to iCAD’s AI-powered ProFound Breast Health Suite and Densitas’ AI solutions to patients and medical professionals worldwide NASHUA, N.H. and HALIFAX, Nova Scotia, April 09, 2024 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a […]

Densitas Announces the Commercial Release of intelliMaven™: The First GPT AI Companion to Elevate Mammography Quality Standards.

Densitas Announces the Commercial Release of intelliMaven™: The First GPT AI Companion to Elevate Mammography Quality Standards.

April 3, 2024

The market leader in Operational AI solutions will showcase its new GPT AI solution at the upcoming SBI symposium in Montreal. HALIFAX, NS, April 3rd, 2024 – Densitas®, a global leader in artificial intelligence solutions for breast cancer screening, announces the commercial release of intelliMaven™, a groundbreaking GPT AI assistant for mammography quality. Together with Densitas’ flagship product intelliMammo®, intelliMaven™ […]

1 2 3 … 5 Next

Solutions

Positioning
Compliance
Analytics
Equipment QC
CE Tracking
Density

Company

About
Evidence
News & Press
Partners
Privacy Policy
In Focus
For Media
Contact

Learn More

intelliMammo Quality Improvement
intelliMammo High-Risk Patient Management
DensityAI™

Request a Demo

© 2026 Densitas Inc. All Rights Reserved.